Public market insider selling at Mind Medicine (MindMed) (MMED)

Public market insider selling at Mind Medicine (E:MMED)

Updated Monday Jan 18, 2021 04:43 AM EDT
Jamon Alexander Rahn, a Senior Officer and Director, disposed of 1,360,000 Subordinate Voting Shares on a direct ownership basis at prices ranging from $3.525 to $4.000 between January 11th and 14th, 2021. This represents a $5,101,183 divestment of the company's shares and an account share holdings change of -13.6%.

Mind Medicine (MindMed) is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Headlines: Jan 18, 2021

MMED Insider Holdings Chart

Issuer details as of Jan 18, 2021 4:43 ET

Latest Price
3.93
1 Day Change
-0.51%
52 Week High
6.47
52 Week Low
0.24
QMV ($Mils)
1,241,540,715


Top